Consistent with the growing evidence that humoral immunity plays a crucial role in antitumor immunity in breast cancer, our findings may provide a rationale underlying the association of a high level of HER2‐AAb with favorable prognosis. This evidence concerns the gene ERBB2 and breast cancer.